CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Dr Brian Wilson
Robert L. Noble Prize recipient in 2009
Dr Brian Wilson is internationally recognized for his pioneering research into various optic tools that can be used for minimally-invasive cancer treatment and early diagnosis. In 1981, with Canadian Cancer Society support, he started a program in translational research and collaborative clinical trials of photodynamic therapy (the use of light-activated drugs) for brain, prostate and gastrointestinal cancers.
He has driven the development of fluorescence and other endoscopic imaging techniques – particularly in Barrett’s esophagus and colon cancer – and more recently has developed optical imaging to guide surgery that is being evaluated in clinical trials for head and neck, prostate and brain cancers.
In the last few years, his research has expanded to include development of nanotechnologies in cancer treatment, diagnosis and research.
Dr Wilson has trained more than 50 graduate students, post-doctoral and clinical fellows, many of whom remain in cancer research and practice worldwide. He is currently head of the division of biophysics and bio-imaging at the Ontario Cancer Institute and professor of medical biophysics in the faculty of medicine at University of Toronto.
Investing to reduce cancer burden
Last year CCS funded $40 million in cancer research, thanks to our donors. Discover how you can help reduce the burden of cancer.